Search for: "PFIZER"
Results 1521 - 1540
of 4,632
Sort by Relevance
|
Sort by Date
8 Oct 2015, 5:00 am
Charles Pfizer & Co., 532 P.2d 1377, 1382 (Okla. 1974); Dole Food Co. v. [read post]
6 Oct 2015, 9:17 am
Pfizer moved to exclude plaintiffs’ medical causation expert witnesses, Dr. [read post]
3 Oct 2015, 9:00 pm
Robert Kramer of Dentons US LLP, Chris Mammen of Hogan Lovells, and Bryan Zielinski of Pfizer Inc. will analyze several recent Federal Circuit opinions that cite Nautilus with different results -- e.g., Teva v. [read post]
29 Sep 2015, 12:34 pm
KAPPOS: ''Companies like Microsoft and Apple and GE -- all of whom are members [of the Partnership for American Innovation] along with IBM, Ford, DuPont and Pfizer as well as smaller companies like Many Worlds and Second Sight -- all of them are engaged in the hard work of making major, I’ll call it bone-grinding innovations. [read post]
29 Sep 2015, 12:34 pm
KAPPOS: ''Companies like Microsoft and Apple and GE -- all of whom are members [of the Partnership for American Innovation] along with IBM, Ford, DuPont and Pfizer as well as smaller companies like Many Worlds and Second Sight -- all of them are engaged in the hard work of making major, I’ll call it bone-grinding innovations. [read post]
28 Sep 2015, 9:58 am
It is not free to access so the IPKat cannot post a functioning link, but readers with access should be able to find it readily.Indian Patent Office rejects Pfizer patent application for Tofacitinib Spicy IP reports in a two-part blogpost by Madhulika Vishwanathan (here and here) that the Indian Patent Office has rejected a Pfizer application for a single stereoisomer of the rheumatoid arthritis drug Tofacitinib, on grounds of anticipation by prior… [read post]
18 Sep 2015, 10:02 am
A European patent for the drug was granted to Warner-Lambert Co, LLC ("Warner-Lambert")(now a subsidiary of Pfizer Inc.) under EP number 0 641 330. [read post]
18 Sep 2015, 9:11 am
Pfizer, No. 4:15-cv-01072, 2015 WL 5243876 (E.D. [read post]
14 Sep 2015, 11:58 am
FDA Reviews Eliquis Data and Finds Safety Problems As More Lawsuits are Filed For the last few years, BristolMyers Squibb and Pfizer have pushed their joint anticoagulant, Eliquis, as safer than many other anticoagulants out on the market, including Pradaxa, Coumadin/warfarin, and Xarelto – all of which face personal injury and wrongful death lawsuits. [read post]
11 Sep 2015, 4:00 am
For example, in a motion for an interlocutory injunction sought by Pfizer against the introduction of CIALIS by Eli Lilly (see 2004 FC 223), Justice Blais summarized the evidence and held, “I am not convinced that the plaintiff will suffer irreparable harm since the losses that Pfizer will incur by sharing the market with Lilly are reasonably calculable, and the other harm claimed by Pfizer is entirely of a speculative nature. [read post]
10 Sep 2015, 5:47 pm
Flash forward one hundred or so years and look at the recent Pfizer case in England:From Bloomberg:Pfizer Inc. was accused by a U.K. judge of making “groundless threats” of legal action against British doctors and drugstores if they prescribed or sold a generic version of its best-selling Lyrica treatment.Judge Richard Arnold issued the rebuke as he ruled that Allergan Plc’s Actavis unit didn’t infringe Pfizer patents with its version of the drug… [read post]
10 Sep 2015, 8:32 am
He also found Pfizer liable for making groundless threats of patent infringement proceedings, albeit not in all the cases alleged by Actavis.The decision is massive even by the standards of Mr Justice Arnold, running to 727 paragraphs and 174 pages. [read post]
3 Sep 2015, 7:34 am
Eliquis, manufactured by Bristol-Myers Squibb (BMS) and Pfizer, is now claiming its new oral anticoagulant (NOAC) is safer than other NOACs (Xarelto, Pradaxa, and Savaysa), according to a recent news article from Medpage Today. [read post]
1 Sep 2015, 7:10 am
APB 23 requires management to assert the unknowable in order to achieve the book income advantage of suppressing a DTL.[4] Companies cannot reliably assert, whether as a probability or a possibility, that certain income will not be repatriated in the next 20 or 30 years (which is how “indefinitely” needs to be defined for accounting consistency).[5] Changes in management, business circumstances, and shareholder needs make such assertions… [read post]
31 Aug 2015, 7:31 am
Additional Resources: UPDATED: J&J-Bayer and Pfizer-BMS look for marketing advantages in real-world Xarelto, Eliquis data, September 2, 2015, FiercePharma, by Carly Herald More Blog Entries: Risk for Internal Bleeding after Taking Pradaxa, August 22, 2014, Boston Dangerous Drugs Injury Lawyer Blog The post Xarelto and Eliquis Makers Fighting for Market Share Despite Safety Risks appeared first on Product Liability Lawyer Blog. [read post]
14 Aug 2015, 7:16 am
Pfizer reached a $190 million Neurontin class action settlement with direct purchasers of the drug (consumers) in April.link: http://www.sommerspc.com/blog/2014/06/pfizer-pays-for-off-label-promotion-of-its-blockbuster-drug-neurontin/ [read post]
9 Aug 2015, 4:28 am
Pfizer’s subsequent attempt to re-brand Viagra from the name it was already called in China (伟哥, or “Weige”) to its preferred choice (万艾可, or “Wan’aike”) was doomed from the start, as evidenced by a series of expensive court cases that Pfizer kept losing. [read post]
29 Jul 2015, 7:41 pm
Heavey, “FDA warns Pfizer for not reporting side effects” (June 10, 2010). [read post]
20 Jul 2015, 9:56 am
The Partnership for American Innovation (Apple, Du Pont, Ford, GE, IBM, Microsoft, Pfizer, etc.) have put together a new, somewhat cheesy, video on how the patent system is driving innovation: [read post]
16 Jul 2015, 4:00 am
Pfizer Ireland Pharmaceuticals 2006 FC 1465, where Lilly sought to impeach Pfizer’s patent on the Cialis drug and sought to get access to communications between the inventors and the U.K. [read post]
